Donald Trump Pharma Tariff: US President Donald Trump announced to impose 100 percent tariffs on the import of branded and patent drugs last week. It is expected to be implemented from October 1, 2025. Companies were excluded from the purview of this tariff, who are building their manufacturing plant in America. Its purpose is to encourage domestic production of drugs in America and eliminate dependence on foreign companies. However, even after the passing of October 1, this tariff did not apply, why? Let’s know

Why the delay in implementing tariffs?

The reason behind this delay is that Trump’s government wants to bring their manufacturing on track by interacting with pharmaceutical companies before putting tariffs. Also, proposals to reduce the prices of medicines of many companies are also being considered. It has been said by the White House that since the talks are still going on, there is a delay in implementing the tariff, but can be implemented in future. That is, its danger is not completely averted yet. If Trump’s 100 percent pharma tariff is implemented, medicines imported from abroad will become expensive for patients. Axperts also say that this may spoil the relationship between trade partners and can cause interruptions in the global supply chain.

Fizzer deal with Trump administration

Meanwhile, Pharmazer, a large company in the pharmaceutical industry, has said to invest $ 70 billion in the US under a deal with the US government. Also promised to reduce the prices of medicines. This shows that the company is trying to increase the scope of its work in America. Meanwhile, Pharmazer, a large company in the pharmaceutical industry, has said to invest $ 70 billion in the US under a deal with the US government. Also promised to reduce the prices of medicines. This shows that the company is trying to increase the scope of its work in America.

#Breakingnews: Today, Pfizer Announced a Historic and Voluntary Agreement with @Potus That will ensure American Patients pay lower pris for their prescription medicines. With this agreement in place, we can invest even more boldly in the US – fueling growth, creating jobs,… pic.twitter.com/im8bjl7yxq

– Pfizer Inc. (@Pfizer) September 30, 2025

Preparation for launch website in the name of Trump

According to a report, in the meantime, Trump’s government is thinking about launching a website that will mention the medicine given on a discount. With the help of this website, patients will help in purchasing medicines at discounts directly from companies. It can be named ‘Trumprx’. That is, it will act like a search tool, through which the patients will know how much discount on which platform is being given on which medicine.

Also read:

Is India scared of Trump’s threats? Russia reduced oil purchases in September, government companies reduced imported

Trump pharma tariff: The Indian stock market declined on Tuesday on Tuesday, the fifth day of tension between Iran and Israel. Today the Nifty slipped below 24,900 points. All the sectors closed on the red mark except IT. The Sensex fell 212 points to close at 81,583, while the Nifty fell 50 93 points to close at 24,853. The Nifty midcap and smallcap index also closed down by 0.5 percent.

Pharma companies decline in shares

Today, the shares of pharma companies also declined by 4 percent as US President Donald Trump says that he is going to impose tariffs very soon on the pharma sector. Today, after this announcement of Trump, Aurobindo Pharma shares fell 4 percent to Rs 1,094.4. Similarly, lupine, granules and Natco Pharma recorded a decline of 3-4 percent.

The share price of Laus Labs, Dr. Reddy’s, Sun Pharma and Glenmark Pharma has also declined by 2-3 percent. Amid this decline in shares of pharma companies, the Nifty Pharma Index saw a weakness of 2.2 percent. Out of 20, 19 stocks were trading in red mark.

Trump threatened to put tariff on pharma sector

In April, Trump announced to impose reciperoot tariffs on 60 countries of the world except the pharma sector. During that time, Trump had said that tariffs will be installed at the level on the pharma sector, which you have never seen before. Actually, Trump wants to put a tariff on pharmaceuticals products because he feels that America will benefit from it. If the dependence on imports is low, then the production of medicines in the US will increase. With this, Americans will also get medicines cheaper.

Trump’s decision affects India

Trump’s decision is going to have a big impact on India because India is one of the biggest suppliers of medicines for America. If Trump puts tariffs on pharmaceutical products, then it will cause great damage to India’s pharma sector. In 2024, India exported US $ 12.72 billion pharmaceutical products to the US.

Also read:

Government ready to sell its stake in these 5 banks, amazing boom in shares; Buying competition